Rivaroxaban dispersible tablet (上海奥全)

利伐沙班分散片(上海奥全)

Report date: 2026/04/03 20:03:44

Base Information

Drug NameRivaroxaban dispersible tablet (上海奥全)
Drug Alias NameAususvarASN-006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsVenous Thromboembolism
Global Approved IndicationsVenous Thromboembolism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/05/20
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesShanghai Auson Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAuson Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsVenous Thromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A